| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.82▼ | 3.84▼ | 3.84▼ | 3.80▲ | 4.09▼ |
| MA10 | 3.84▼ | 3.84▼ | 3.82▼ | 3.82▼ | 4.48▼ |
| MA20 | 3.86▼ | 3.81▼ | 3.80▼ | 4.26▼ | 4.50▼ |
| MA50 | 3.82▼ | 3.80▼ | 3.84▼ | 4.66▼ | 5.49▼ |
| MA100 | 3.80▼ | 4.06▼ | 4.34▼ | 4.52▼ | 6.41▼ |
| MA200 | 4.14▼ | 4.46▼ | 4.53▼ | 5.57▼ | 11.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | 0.000▲ | 0.010▲ | -0.026▼ | -0.065▼ |
| RSI | 39.519▼ | 44.004▼ | 44.314▼ | 36.892▼ | 39.768▼ |
| STOCH | 13.492▼ | 46.667 | 53.764 | 34.384 | 19.538▼ |
| WILL %R | -100.000▼ | -100.000▼ | -77.778▼ | -81.728▼ | -89.062▼ |
| CCI | -258.402▼ | -65.649 | -24.853 | -47.254 | -118.185▼ |
| CDL | $SCYX Engulfing Candlestick Pattern Detected | Set Alert |
|
Tuesday, August 25, 2026 12:06 PM
JERSEY CITY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat ...
|
|
Thursday, March 12, 2026 12:37 AM
On February 26, 2026, SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the first participants had been dosed in a Phase 1 single ascending dose and multiple ascending dose trial evaluating the intravenous ...
|
|
Thursday, May 29, 2025 12:36 AM
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/10/26 | 3.78 | 3.90 | 3.78 | 3.81 | 64,010 |
| 23/10/26 | 3.80 | 3.84 | 3.71 | 3.785 | 54,998 |
| 22/10/26 | 3.75 | 3.91 | 3.75 | 3.81 | 39,077 |
| 21/10/26 | 3.89 | 3.98 | 3.76 | 3.785 | 70,202 |
| 20/10/26 | 3.66 | 3.90 | 3.66 | 3.80 | 54,621 |
| 19/10/26 | 3.705 | 3.83 | 3.66 | 3.66 | 76,342 |
| 16/10/26 | 3.87 | 3.88 | 3.535 | 3.67 | 189,485 |
| 15/10/26 | 3.96 | 3.97 | 3.78 | 3.91 | 69,669 |
| 14/10/26 | 4.00 | 4.08 | 3.90 | 3.96 | 44,601 |
| 13/10/26 | 4.03 | 4.09 | 3.92 | 3.99 | 66,761 |
|
|
||||
|
|
||||
|
|